Sign In  |  Register  |  About Corte Madera  |  Contact Us

Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast | Traffic
  • Search Hotels in Corte Madera

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Multiple Myeloma Market to Reach USD 31 Billion by 2026 Driven by the High Emphasis on the Treatment of the Aggressive Form of the Disease, says Fortune Business Insights™

Pune, April 29, 2020 (GLOBE NEWSWIRE) -- The global multiple myeloma market size is projected to reach USD 31 billion by the end of 2026. The high prevalence of the disease will emerge in favor of the companies operating in the market. According to a report published by Fortune Business Insights, titled “Multiple Myeloma Market Size, Share & Industry Analysis, By Drug Class (Immunomodulators, Proteasome Inhibitor, Anti-CD38 Monoclonal Antibody, Alkylating Agents, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies), and Regional Forecast, 2019-2026,” the market was worth USD 19.48 billion in 2018 and will exhibit a CAGR of 6.0% during the forecast period, 2019-2026.



Request a Sample Copy of the Research Report:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/multiple-myeloma-market-102693



Multiple myeloma is a rare form of cancer that has a direct impact on the blood in the human body. Due to the effects of blood disorders, there has been a huge emphasis on the development of drugs associated with the treatment of the disease. The increasing investment in the R&D of products by large scale companies across the world will bode well for the market in recent years. Advances in ongoing clinical trials associated with the treatment of the disease, will open up a huge potential for the companies operating in the market. The presence of several large scale companies will bode well for the market in the foreseeable future.


An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

To get the short-term and long-term impact of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/multiple-myeloma-market-102693



Increasing Investment in Product R&D Will Aid Growth

The report encompasses several factors that have contributed to the growth of the market in recent years. Among all factors, high investment in research and development of newer products has made a huge impact on the growth of the overall market. In April 2019, the ‘Multiple Myeloma Research Foundation’ announced the launch of a new investment fund for the treatment options in multiple myeloma. The MMRF introduced ‘Myeloma Investment Fund’ foe the development of clinical trials of ongoing drugs associated with the treatment of the disease. This investment will have a massive impact on the growth of the overall market in the coming years.



Quick Buy -  Multiple Myeloma Market Research Report:
https://www.fortunebusinessinsights.com/checkout-page/102693



North America Currently Dominates the Market; Increasing Investment in Product R&D by Major Companies to Aid Growth

The report analyzes the ongoing multiple myeloma market trends across North America, Latin America, Asia Pacific, the Middle East and Africa, and Europe. Among these regions, the market in North America currently dominates the market. The high investment put in by government and leading organizations will bode well for the market in North America. As of 2018, the market in North America was worth USD 11.40 billion and this value is projected to increase further in the coming years. The market in Europe will emerge as the second largest market in the coming years, driven by the presence of several large scale companies in several countries across this region.



List of the leading companies that are operating in the global multiple myeloma market include:

•              Takeda Pharmaceutical Company Limited

•              Novartis AG

•              Teva Pharmaceutical Industries Ltd.

•              Bristol Myers Squibb Company

•              Amgen Inc.

•              ONO PHARMACEUTICAL CO., LTD.

•              Janssen Pharmaceuticals, Inc.

•              Genentech, Inc. (F. Hoffmann-La Roche Ltd)

•              CELGENE CORPORATION (Bristol Myers Squibb Company)

•              AbbVie Inc.

•              Sanofi

•              Karyopharm

•              Others



Industry Developments:

December 2019: The first clinical data released for BCMAxCD3 bispecific antibody, showed positive preliminary results for the treatment of multiple myeloma.



Have Any Query? Ask Our Experts:
 https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/multiple-myeloma-market-102693



Detailed Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Prevalence of Multiple Myeloma - by Key Countries - 2018
    • Pipeline Analysis
    • Key Industry Developments
    • Regulatory Scenario, by Key Regions
    • Analysis Of Economic Burden of Multiple Myeloma Treatment
    • New Product Launches
    • Overview of Emerging Treatments for Multiple Myeloma
  • Global Multiple Myeloma Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Drug Class
      • Immunomodulators
      • Proteasome Inhibitor
      • Anti-CD38 Monoclonal Antibody
      • Alkylating Agents
      • Others
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies & Drug Stores
      • Online Pharmacies
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa

TOC Continued….!!!



Request for Customization:  
https://www.fortunebusinessinsights.com/enquiry/customization/multiple-myeloma-market-102693



Have a Look at Related Reports:

Breast Cancer Therapeutics Market Size, Share and Global Trend By Therapy (Targeted Therapy, Hormonal Therapy, Chemotherapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Cancer Type (Hormone Receptor, HER2+), and Geography Forecast till 2026

Lung Cancer Therapeutics Market Size, Share and Global Trend By Therapy (Targeted, Therapy, Immunotherapy, Chemotherapy), By Cancer Type (Non-small cell lung cancer (NSCLC), Small cell lung cancer (SCLC)), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography Forecast till 2026

Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026

Non-Hodgkin Lymphoma Treatment Market Size, Share & Industry Analysis, By Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, and Others), By Disease Type (B-cell Lymphoma, and T-cell Lymphoma), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, and Online Pharmacies), and Regional Forecast, 2019-2026

Cancer Biomarkers Market Size, Share & Industry Analysis, By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, and Others), By Biomarker Type (PSA, HER-2, EGFR, KRAS, and Others), By End User (Pharmaceutical & Biotechnology Companies, Diagnostics & Research Laboratories, Hospitals & Specialty Clinics, and Others), and Regional Forecast, 2019-2026


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Press Release:  https://www.fortunebusinessinsights.com/press-release/multiple-myeloma-market-9837

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.